Identification of Glandular (Acinar)/Tubule Formation in Invasive Carcinoma of the Breast: A Study to Determine Concordance Using the World Health Organization Definition
Yungtai Lo(Albert Einstein College of Medicine), Susan Fineberg(Albert Einstein College of Medicine), Stuart J. Schnitt(Brigham and Women's Hospital), Shabnam Jaffer(North Shore Diabetes and Endocrine Associates), Gulisa Turashvili(Harvard University), Fnu Sapna(Albert Einstein College of Medicine), Laleh Hakima(University of North Carolina Hospitals), Susan C. Lester(University of Vermont), Berrin Ustun(Albert Einstein College of Medicine), Kamaljeet Singh, Andrea Flieder, Jordan Baum, Yujun Gan(Dartmouth–Hitchcock Medical Center), Ami Patel(University of Maryland, Baltimore), Ava Bhattarai(Methodist University Hospital), Marie-Hélène Ngo(Brigham and Women's Hospital), Bryan Harmon(Albert Einstein College of Medicine), Ayşegül A. Şahin(The University of Texas MD Anderson Cancer Center), Jennifer Zeng(Icahn School of Medicine at Mount Sinai), Rana Aldrees(Brigham and Women's Hospital), Javier A. Laurini(Albert Einstein College of Medicine), Timothy M. D’Alfonso(Northwell Health), Malini Harigopal, Ali Amin(Brown University), Sara Abbott(University of Michigan), Celina G. Kleer(University of Michigan), Thaer Khoury, William S. Towne(NewYork–Presbyterian Hospital), Paula S. Ginter, Ian O. Ellis(University of Nottingham), Aziza Nassar(Mayo Clinic in Florida), Miglena K. Komforti(Albert Einstein College of Medicine), Yihong Wang(Wuxi People's Hospital), Sandra J. Shin(Cornell University), Dara S. Ross(Memorial Sloan Kettering Cancer Center), Sunil Shankar Badve(Emory University Hospital), Sonali Lanjewar(Albert Einstein College of Medicine), Victoria Collins(Icahn School of Medicine at Mount Sinai), Robert Bradley, Ukuemi Edema(Albert Einstein College of Medicine)
Cited by 1
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
|Cancer Cell|2004|1.9k
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
|Nature Communications|2016|1.8k